Case number 5:20-cv-00023
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Aurobindo Pharma Ltd. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 19, 2021 | N/A | Notice (Other) (0) Docket Text:IMPORTANT NOTICE: The United States District Court for the Northern District of West Virginia (WVND) will be upgrading its current CM?ECF system to Next Generation of CM/ECF (NextGen CM/ECF) on Monday, July 19, 2021. Complete information regarding the WVND NextGen CM/ECF implementation can be found here. Preparing for NextGen Cm/ECF is a two-step process. Step one was to upgrade your PACER account. Each attorney should have their own individual upgraded PACER account at this time. Step two will be to link your upgraded PACER account to your WVND e-fling account in the new NextGen CM/ECF system on or after July 19, 2021. Please log in to the WVND CM/ECF system at https://ecf.wvnd.uscourts.gov/ before July 19, 2021 to make sure you know your current WVND e-filing login and password. Do not rely on your username and password being saved in your web browser, because that method will not work with the NextGen upgrade. If you do not know your login or password or have any additional questions please call the WVND Clerks CM/ECF Office Help Desk at (304) 267-5682. (cmd) (ADI) |
| May 30, 2021 | N/A | Notice (Other) (0) Docket Text:IMPORTANT NOTICE: The United States District Court for the Northern District of West Virginia (WVND) will be upgrading its current CM/ECF system to the Next Generation of CM/ECF (NextGen CM/ECF) on July 19, 2021. Complete information regarding the WVND NextGen CM/ECF implementation can be found here. Currently, many attorneys within a firm may share a single PACER account. This will no longer be allowed with the New WVND NextGen CM/ECF system because each attorney must have an individual upgraded PACER account that will be linked to their e-filing account. Shared PACER accounts cannot be used by WVND e-filing attorneys once the WVND NextGen CM/ECF system is implemented. Preparing for NextGen CM/ECF is a two-step process. Step one is to upgrade your PACER account, and step two is to link your upgraded PACER account to the WVND e-filing account in the upgraded NextGen CM/ECF system. This notice only addresses the first step because the second step cant be completed until on or after July 19, 2021. The first step is to check and see if your PACER account is an upgraded PACER account. Many PACER accounts have already been upgraded. If any of the following is true, you have un upgraded PACER account and no action is required until after the WVND NextGen CM/ECF upgrade occurs on July 19, 2021: 1) You have a an upgraded PACER account for another NextGen court; or 2) Your PACER account was created after August 10, 2014. If none of these are true, you must upgrade your legacy PACER account before you will be able to link your PACER account to your current WVND CM/ECF account for your new NextGen CM/ECF account. Additional notices will be sent later detailing how to handle the second step in this process. If you still have questions, please contact the PACER Service Center at 800-676-6856 or the WVND Clerks Office CM/ECF Help Desk at (304) 267-5682. (cmd) (ADI) |
| Feb 2, 2021 | 39 | Order on Motion for Leave to Appear (1) Docket Text:ORDER granting [36] Motion for Leave to Appear Pro Hac Vice by Jessica Tyrus Mackay. Signed by Senior Judge Irene M. Keeley on 2/2/2021. (ag) |
| Feb 2, 2021 | 38 | Order on Motion for Leave to Appear (1) Docket Text:ORDER granting [35] Motion for Leave to Appear Pro Hac Vice by Erin Marie Kautz. Signed by Senior Judge Irene M. Keeley on 2/2/2021. (ag) |
| Feb 2, 2021 | 36 | Motion for Leave to Appear (3) Docket Text:Application for Admission Pro Hac Vice Other Document Jessica Tyrus Mackay filed by Aurobindo Pharma Ltd.. (Pizzo, John) Modified event type on 2/2/2021 (nmm). |
| Feb 2, 2021 | 35 | Motion for Leave to Appear (3) Docket Text:Application for Admission Pro Hac Vice Other Document Erin Marie Kautz filed by Aurobindo Pharma Ltd.. (Pizzo, John) Modified event type on 2/2/2021 (nmm). |
| Jan 22, 2021 | N/A | Set/Reset Hearings (0) Docket Text: Set/Reset Hearings: Claim construction hearing set for 2/10/2021 10:00 AM before Senior Judge Irene M. Keeley per de 98 order in 1:20cv19. (jss) |
| Jun 16, 2020 | 34 | Answer to Counterclaim (7) Docket Text:Plaintiff's Answer to Defendant's Counterclaims ANSWER to [30] Answer to Complaint,, Counterclaim, by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc..(Companion, James) |
| Jun 16, 2020 | N/A | Set/Reset Deadlines (0) Docket Text: Set/Reset Deadlines: Fact Discovery due by 2/26/2021. (jss) |
| Jun 16, 2020 | N/A | Set Deadlines/Hearings (0) Docket Text: Set Deadlines/Hearings per Order de 52 filed in 1:20cv19 adopting scheduling order. Motions due by 8/10/2021. Pretrial Order due by 12/17/2021. Bench Trial set for 1/24/2022 09:00 AM in Clarksburg District Judge Courtroom, 2nd Floor before Senior Judge Irene M. Keeley (5 days) Pretrial Conference and Settlement Conference set for 1/14/2022 10:00 AM in Clarksburg District Judge Courtroom, 2nd Floor before Senior Judge Irene M. Keeley. Claim Construction Hearing set for 1/20/2021 10:00 AM in Clarksburg District Judge Courtroom, 2nd Floor before Senior Judge Irene M. Keeley. Status Conference set for 7/20/2021 01:00 PM before Senior Judge Irene M. Keeley. (jss) |
| Jun 15, 2020 | 33 | Order on Motion to Consolidate Cases (3) Docket Text: ORDER GRANTING [31] MOTION TO CONSOLIDATE: it is hereby ORDERED that the two above-styled cases shall be CONSOLIDATED for all purposes, and the lead case shall proceed under Civil Action 1:20-cv-19. Signed by District Judge John Preston Bailey on 6/15/2020. (copy to counsel via cm/ecf) (nmm) |
| Jun 15, 2020 | N/A | Add and Terminate Judges (0) Docket Text: Senior Judge Irene M. Keeley added; District Judge John Preston Bailey no longer assigned to case. (nmm) |
| Jun 15, 2020 | N/A | Create Case Association (0) Docket Text: Cases associated: Create association to 1:20-cv-00019-IMK per [33] Order. (nmm) |
| May 27, 2020 | 32 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Shawn A. Morgan on behalf of Aurobindo Pharma Ltd. (Morgan, Shawn) |
| May 26, 2020 | 31 | Motion to Consolidate Cases (4) Docket Text: MOTION to Consolidate Cases by Aurobindo Pharma Ltd.. (Pizzo, John) |
| May 26, 2020 | 30 | Civil Cover Sheet (1) |
| May 26, 2020 | 30 | Main Document (15) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc. by Aurobindo Pharma Ltd.. (Attachments: # (1) Civil Cover Sheet)(Pizzo, John) |
| May 5, 2020 | 29 | Order on Motion for Leave to Appear (1) Docket Text: ORDER granting [21] Motion for Leave to Appear Pro Hac Vice for James F. Hurst. Signed by District Judge John Preston Bailey on 5/5/2020. (copy to counsel via cm/ecf) (nmm) |
| May 5, 2020 | 28 | Order on Motion for Leave to Appear (1) Docket Text: ORDER granting [20] Motion for Leave to Appear Pro Hac Vice for Bryan S. Hales. Signed by District Judge John Preston Bailey on 5/5/2020. (copy to counsel via cm/ecf) (nmm) |
| May 5, 2020 | 27 | Order on Motion for Leave to Appear (1) Docket Text: ORDER granting [24] Motion for Leave to Appear Pro Hac Vice. Signed by District Judge John Preston Bailey on 5/5/2020. (ag) |
| May 5, 2020 | 26 | Order on Motion for Leave to Appear (1) Docket Text: ORDER granting [23] Motion for Leave to Appear Pro Hac Vice. Signed by District Judge John Preston Bailey on 5/5/2020. (ag) |
| Apr 30, 2020 | 24 | Proposed Order (1) |
| Apr 30, 2020 | 24 | Main Document (4) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Jeffrey Stephen Ward by Aurobindo Pharma Ltd.. (Attachments: # (1) Proposed Order)(Pizzo, John) |
| Apr 30, 2020 | 23 | Proposed Order Proposed Order (1) |
| Apr 30, 2020 | 23 | Main Document (4) Docket Text: MOTION for Leave to Appear Pro Hac Vice for Wendy M. Ward by Aurobindo Pharma Ltd.. (Attachments: # (1) Proposed Order Proposed Order)(Pizzo, John) |
| Apr 20, 2020 | 20 | Attachment (1) |
| Apr 20, 2020 | 20 | Proposed Order (1) |
| Apr 20, 2020 | 20 | Main Document (2) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Bryan S. Hales by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: # (1) Attachment, # (2) Proposed Order)(Companion, James) |
| Apr 20, 2020 | 21 | Proposed Order (1) |
| Apr 20, 2020 | 21 | Main Document (2) Docket Text: MOTION for Leave to Appear Pro Hac Vice of James F. Hurst by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(Companion, James) |
| Apr 3, 2020 | 19 | Order on Motion to Withdraw (1) Docket Text: ORDER granting [17] Motion to Withdraw: Attorney Leora Ben-Ami terminated. Signed by District Judge John Preston Bailey on 4/3/2020. (copy to counsel via cm/ecf) (nmm) |
| Apr 2, 2020 | 18 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by John D. Pizzo on behalf of Aurobindo Pharma Ltd. (Pizzo, John) |
| Apr 2, 2020 | 17 | Proposed Order (1) |
| Apr 2, 2020 | 17 | Main Document (2) Docket Text: MOTION to Withdraw of Atty. Leora Ben-Ami as counsel for Plaintiffs by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(Companion, James) |
| Feb 24, 2020 | 16 | Order on Motion for Leave to Appear (1) Docket Text: ORDER granting [9] Motion for Leave to Appear Pro Hac Vice for Jeanna Wacker. Signed by District Judge John Preston Bailey on 2/24/2020. (copy to counsel via cm/ecf) (nmm) |
| Feb 24, 2020 | 15 | Order on Motion for Leave to Appear (1) Docket Text: ORDER granting [8] Motion for Leave to Appear Pro Hac Vice for Mira Mulvaney. Signed by District Judge John Preston Bailey on 2/24/2020. (copy to counsel via cm/ecf) (nmm) |
| Feb 24, 2020 | 14 | Order on Motion for Leave to Appear (1) Docket Text: ORDER granting [7] Motion for Leave to Appear Pro Hac Vice for Leora Ben-Ami. Signed by District Judge John Preston Bailey on 2/24/2020. (copy to counsel via cm/ecf) (nmm) |
| Feb 24, 2020 | 13 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharma GmbH & Co. KG. Aurobindo Pharma Ltd. waiver sent on 2/24/2020, answer due 5/26/2020. (Companion, James) |
| Feb 13, 2020 | 12 | Order on Motion to Withdraw (1) Docket Text: ORDER granting [10] Plaintiff's Motion for Leave to Withdraw As Counsel and ORDERS that Attorneys Thomas F. Fleming, Sam Kwon, Ashley Ross and Christopher J. Citro are hereby withdrawn as counsel for the Plaintiffs in this matter. Signed by District Judge John Preston Bailey on 2/13/2020. (copy to counsel via cm/ecf) (nmm) |
| Feb 13, 2020 | 10 | Proposed Order (1) |
| Feb 13, 2020 | 10 | Main Document (2) Docket Text: MOTION to Withdraw as Counsel of Attorneys Thomas F. Fleming, Sam Kwon, Ashley Ross and Christopher J. Citro by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(Companion, James) |
| Feb 13, 2020 | 9 | Proposed Order (1) |
| Feb 13, 2020 | 9 | Main Document (2) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Jeanna Wacker by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(Companion, James) |
| Feb 13, 2020 | 8 | Proposed Order (1) |
| Feb 13, 2020 | 8 | Main Document (2) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Mira Mulvaney by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(Companion, James) |
| Feb 13, 2020 | 7 | Proposed Order (1) |
| Feb 13, 2020 | 7 | Main Document (2) Docket Text: MOTION for Leave to Appear Pro Hac Vice of Leora Ben-Ami by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc.. (Attachments: # (1) Proposed Order)(Companion, James) |
| Feb 5, 2020 | 1 | Main Document (8) Docket Text: COMPLAINT against Aurobindo Pharma Ltd., filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharma GmbH & Co. KG. (Attachments: # (1) Exhibit 1 - Patent Appplication Publication, # (2) Civil Cover Sheet) (copy to counsel via cm/ecf) (nmm) |
| Feb 5, 2020 | 6 | Notice of Verification of Attorney Admission (1) Docket Text: VERIFICATION OF ATTORNEY ADMISSION to Attys. Ben-Ami, Flemming, Wacker, Mulvaney, Kwon, Ross and Citro (nmm) |
| Feb 5, 2020 | 4 | Report Re: Patent/Trademark (1) Docket Text: REPORT to USPTO on the filing or determination of an action regarding re [1] Complaint. (copy to counsel via cm/ecf) (nmm) |
| Feb 5, 2020 | 3 | Corporate Disclosure Statement (2) Docket Text: Corporate Disclosure Statement identifying Corporate Parent C.H. Boehringer Sohn AG & Co. KG for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc. (copy to counsel via cm/ecf) (nmm) |
| Feb 5, 2020 | 2 | Other Document (2) Docket Text: SUPPLEMENTAL INFORMATION FOR PATENT CASES INVOLVING AN ABBREVIATED NEW DRUG APPLICATION (ANDA) filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc. (copy to counsel via cm/ecf) (nmm) |
| Feb 5, 2020 | 1 | Civil Cover Sheet (1) |
| Feb 5, 2020 | 1 | Exhibit 1 - Patent Appplication Publication (18) |
| Feb 5, 2020 | 1 | Complaint* (1) |
